SCHEMBL6504616

SCHEMBL6504616

CC(NC(=O)C1CCN(C(=O)/C=C/c2ccc(F)c(F)c2F)CC1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
C3AR1 Q16581 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ITGB2 P05107 2/20 0.40
ICAM1 P05362 2/20 0.40
ITGAL P20701 2/20 0.40
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
CCR2 P41597 1/20 0.38
APOBEC3A P31941 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
CASP3 P42574 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6504618 1.00 CAPN1 (0.46) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6495682 0.91 CAPN1 (0.47) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6495687 0.91 CAPN1 (0.47) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6497914 0.88 CAPN1 (0.44) CAPN1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL6497917 0.88 CAPN1 (0.44) CAPN1SMN1; SMN2NPC1RAB9AMEN1
SCHEMBL6495775 0.88 ITGAL (0.49) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6495771 0.88 ITGAL (0.49) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL8296744 0.88 ITGAL (0.49) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6496329 0.85 SMN1; SMN2 (0.55) CAPN1SMN1; SMN2NPC1RAB9AC3AR1
SCHEMBL6500473 0.85 SMN1; SMN2 (0.66) CAPN1SMN1; SMN2NPC1RAB9AC3AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed